BRAINWEAR

Clinical trial is now closed

We have developed and led a number of near-patient sensing and reporting studies in cancer patients, as well as computational tools for measuring patient outcomes and experience.

The BrainWear clinical trial was the first trial in the world to look at using activity monitoring in patients with brain tumours.

BrainWear closed in 2022, after recruiting almost 100 patients and carers from the brain tumour community. The results have been presented at multiple national and international meetings.

Related papers can also be found in the Publications section.

BrainWear: Research

PUBLISHED WORK

P11.03 SLEEP ANALYSIS OF ACCELEROMETER DATA FROM HIGH GRADE GLIOMA PATIENTS IN THE BRAINWEAR STUDY

September 2021

M George, S Dadhania, M Williams

OS10.5.A BRAINWEAR: LONGITUDINAL, OBJECTIVE ASSESSMENT OF PHYSICAL ACTIVITY IN 42 HGG PATIENTS

September 2021

S Dadhania, L Pakzad-Shahabi, S Mistry, K Le Calvez, W Saleem, W Mohammed, M Williams

EARLY EFFECTS OF SURGERY AND RADIOTHERAPY ON ACTIVITY LEVELS IN PATIENTS WITH BRAIN TUMOURS: PRELIMINARY DATA FROM THE BRAINWEAR TRIAL

October 2019

Dadhania S, Wei Wang J, Yu B, Saleem W, Blake C, Shahabi L, Williams M